“…Tyrosinase is a copper-containing oxidoreductase catalyzing the hydroxylation of monophenols to o-diphenols and their subsequent oxidation to o-quinones (Robb, 1984). This enzyme has found promising potential in broad applications such as wastewater treatment (Atlow et al, 1984;Xu et al, 2013), biosensor design (Nistor et al, 1999;Wang et al, 2015;Lu et al, 2016), synthesis of pharmaceuticals and nutraceuticals (Pialis et al, 1998;Cheng et al, 2018;Wei et al, 2020b), and prodrug activation for cancer therapy (Lian et al, 2018). Our previous work has demonstrated that this enzyme, when immobilized as cross-linked enzyme aggregates (CLEAs) (Xu et al, 2011), tyrosinase-Cu 3 (PO 4 ) 2 hybrid composites (TCHCs) (Wei et al, 2020b), and tyrosinase@ZIFs (here ZIFs = zeolitic imidazolate frameworks, a type of MOFs) (Wei et al, 2021), had its stability signi cantly enhanced as compared to the free enzyme.…”